We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about ... up to its next earnings release, or is Glaxo due for a pullback? Before we dive into how ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

GSK reported core earnings of 59 cents per American ... digit percentage from prior expectation of being stable. Currently, Glaxo has an average Growth Score of C, a grade with the same score ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

Nairobi — UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025. The rebrand comes after GSK transferred its consumer health business to Haleon to ...

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

GSK (GlaxoSmithKline) is due to close its Ulverston factory in June, bringing to an end 75 years of history, and we’re remembering what the pharmaceutical giant has meant to the town and the ...

The $16 billion dollar 'asset swap' deal between GlaxoSmithKline (GSK) and Novartis has been formally completed today, with the UK-headquartered company exchanging its oncology portfolio for the ...